Smith & Nephew Overview
- Year Founded
-
1855
- Status
-
Public
- Employees
-
19,000
- Stock Symbol
-
SN.
- Investments
-
54
- Share Price
-
$12.17
- (As of Monday Closing)
Smith & Nephew General Information
Description
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 41% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Contact Information
- Building 5, Croxley Park
- Hatters Lane
- Watford WD18 8YE
- England, United Kingdom
Smith & Nephew Stock Performance
(As of Monday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $12.17 | $11.20 | $10.76 - $16.44 | $10.6B | 873M | 3.02M | $0.25 |
Smith & Nephew Financials Summary
|
In Thousands, USD |
TTM 30-Jun-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 |
|---|---|---|---|---|
| EV | 16,490,266 | 14,022,312 | 17,537,035 | 20,337,734 |
| Revenue | 5,349,000 | 5,215,000 | 5,212,000 | 4,560,000 |
| EBITDA | 876,000 | 860,000 | 1,236,000 | 860,000 |
| Net Income | 218,000 | 223,000 | 524,000 | 448,000 |
| Total Assets | 9,844,000 | 9,966,000 | 10,920,000 | 11,012,000 |
| Total Debt | 3,039,000 | 2,872,000 | 3,339,000 | 3,690,000 |
Smith & Nephew Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Smith & Nephew Comparisons
Industry
Financing
Details
000000
000000
Smith & Nephew Competitors (14)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Orthofix International | Formerly PE-Backed | Lewisville, TX | 0000 | 00000 | 000000000 00 | 00000 |
| 0000000 0000000000 | Corporation | Princeton, NJ | 0000 | 00.00 | 000000000 00 | 00.00 |
| 000000 000000 | Corporation | Warsaw, IN | 00000 | 000.00 | 000000000 00 | 000.00 |
| 000000000 | Corporation | Humlebaek, Denmark | 00000 | 00.000 | 000000000 | 00.000 |
| 00000 00000000 | Private Equity-Backed | Caledonia, MI | 0000 | 0000 | 000000000 | 0000 |
Smith & Nephew Patents
Smith & Nephew Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202003586-D0 | Device, apparatus and method of determining skin perfusion pressure | Inactive | 12-Mar-2020 | 0000000000 | |
| EP-4114330-A1 | Sensor integrated dressings and systems | Pending | 05-Mar-2020 | 000000000000 | |
| GB-202003203-D0 | Sensor integrated dressings and systems | Inactive | 05-Mar-2020 | 000000000000 | |
| JP-2023517174-A | Sensor-integrated coatings and systems | Pending | 05-Mar-2020 | 000000000000 | |
| US-20230090142-A1 | Sensor integrated dressings and systems | Pending | 05-Mar-2020 | A61F13/00029 |
Smith & Nephew Executive Team (64)
Smith & Nephew Board Members (30)
| Name | Representing | Role | Since |
|---|---|---|---|
| 0000 0000000 | Self | Board Member | 000 0000 |
| 00000 000000 | Self | Board Member | 000 0000 |
| 0000-000000000 000 | Smith & Nephew | Chief Financial Officer, Finance & Board Member | 000 0000 |
| 0000000 0000000 | Smith & Nephew | Board Member | 000 0000 |
| 000000 0000 00.0 | Smith & Nephew | Chief Executive Officer & Board Member | 000 0000 |
Smith & Nephew Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Smith & Nephew Investments & Acquisitions (54)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| CartiHeal | 22-Nov-2023 | 0000000000 | 00000 | Therapeutic Devices | 000000 00 |
| Additive Instruments | 09-Mar-2023 | 0000000000 | Surgical Devices | ||
| Miach Orthopaedics | 25-Jan-2023 | 00000 0000 | 0000 | Surgical Devices | |
| Engage Surgical | 18-Jan-2022 | 0000000000 | 00000 | Therapeutic Devices | |
| Integra LifeSciences (Extremity Orthopedic Business) | 04-Jan-2021 | Merger/Acquisition | 00000 | Therapeutic Devices |
Smith & Nephew Subsidiaries (8)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| Rotation Medical | Pharmaceuticals | Plymouth, MN | 2006 |
| EuroCiencia Colombia | Medical Supplies | Bogota, Colombia | 0000 |
| Atracsys | Electronic Equipment and Instruments | Puidoux, Switzerland | 0000 |
| Midland Medical Technologies | Therapeutic Devices | Birmingham, United Kingdom | 0000 |
| Oratec Interventions | Surgical Devices | Manassas, VA | 0000 |
Smith & Nephew ESG
Risk Overview
Risk Rating
Updated September, 27, 2023
25.05 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
00.0
Management
Management is related to actions taken to manage ESG issues
00.00
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
00 of 15,708
Rank
Percentile
Healthcare
Industry
00 of 626
Rank
Percentile
Medical Devices
Subindustry
00 of 213
Rank
Percentile
Smith & Nephew Exits (4)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| OrthoSpace | 01-Dec-2016 | 00 000000000000000 | 000 | Completed |
|
| OrthoSpace | 19-May-2015 | 00 000000000000000 | 000 | Completed |
|
| BSN medical | 01-Apr-2001 | 00000 0000000 | Completed |
|
|
| Jobskin Australia | 01-Jan-1991 | Merger/Acquisition | Completed |